The national heart failure audit for England and Wales 2008-2009

Heart

Volumn 97, Issue 11, 2011, Pages 876-886

  Cleland, John G F ^a   McDonagh, Theresa ^b   Rigby, Alan S ^a   Yassin, Ashraf ^a   Whittaker, Tracy ^c   Dargie, Henry J ^d  

^a UNIVERSITY OF HULL   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c NATIONAL HEALTH SERVICE   (United Kingdom)

^d GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NATRIURETIC FACTOR;

AGE; AGED; ARTICLE; CONTROLLED STUDY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL SPECIALIST; MORTALITY; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROGNOSIS; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ENGLAND; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEDICAL AUDIT; WALES;

EID: 79955893656     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.209171     Document Type: Article

References (22)

1. HES online. 2010. http://www.hesonline.nhs.uk.
2. NHS Institute for Innovation and Improvement. 2010. http://www.institute. nhs.uk/quality-and-service-improvement-tools/quality-and-service-improvement- tools/length.
3. Khand AU, Shaw M, Gemmel I, et al. Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure. Eur J Heart Fail 2005;7:792-7. (Pubitemid 41125895)
4. Cleland JG, Yassin A, Arrow Y, et al. Outcome of patients discharged on loop diuretic therapy with or without a diagnosis of heart failure. Eur J Heart Fail Supplement 2009.
5. Murray GD. A cautionary note on selection of variables in discriminant analysis. Appl Stat 1977;26:246-50.
6. Miller AJ. Selection of subsets of regression variables (with discussion). J R Stat Soc Ser A 1984;147:389-425.
7. Mantel N. Why stepdown procedures in variable selection. Technometrics 1970;12:621-5.
8. Sauerbrei W. The use of resampling methods to simplify regression models in medical statistics. Appl Stat 1999;48:313-29.
9. Schoenfeld D. Partial residual estimation for the proportional hazards regression. Biometrika 1982;69:239-41.
10. Clark AL, Lammiman MJ, Goode K, et al. Is taking part in clinical trials good for your health? Eur J Heart Fail 2009;11:1078-83.
11. Cleland JGF, Swedberg K, Follath F, et al. The Euroheart Failure Survey Programme: survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:422-63.
12. Nicol ED, Fitall B, Roughton M, et al. NHS Heart Failure Survey - a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart 2008;94:172-7. (Pubitemid 351211723)
13. Cleland JGF, Tendera M, Taylor J. Prognosis in heart failure with a normal ejection fraction. N Engl J Med 2007;357:829-30. (Pubitemid 47295663)
14. Caruana L, Petrie MC, Davie AP, et al. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ 2000;321:215-18.
15. Petrie MC, Hogg K, Caruana L, et al. Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction? Heart 2004;90:511-17.
16. Lenzen MJ, Scholte op Reimer WJM, Boersma E, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-20. (Pubitemid 38891571)
17. Cleland JG, McMurray JJ, Kjekshus J, et al. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol 2009;54:1850-9.
18. National Institute for Health and Clinical Exellence. 2008. http://www.nice.org.uk/.
19. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
20. Clark RA, Inglis SC, McAlister FA, et al. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007;334:942.
21. Cleland JGF, Louis AA, Rigby AS, et al; on behalf of the TEN-HMS investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death. The Trans-European Network-Home-Care Management System (TEN-HMS) Study. J Am Coll Cardiol 2005;45:1654-64. (Pubitemid 40704502)
22. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.